Aspects of the teratology of cyclophosphamide (NSC-26271).
Wistar-derived rat embryos were most sensitive to maternally administered cyclophosphamide on Days 9.5 and 10.5 of gestation and to chlorambucil on Day 9.5 of gestation. The spectrum of malformations and the dose-response behavior of both drugs were similar. Chlorambucil was three times more potent than cyclophosphamide on an mg/kg basis. The drugs showed additive behavior when administered in combination. The teratogenic effects of the individual or combined drugs were reduced by protective doses of cysteine or glutathione. Studies with analogs of cyclophosphamide have suggested that the whole molecule is involved in teratogenesis.
D000014:Abnormalities, Drug-Induced; D000478:Alkylation; D000818:Animals; D055598:Chemical Phenomena; D002621:Chemistry; D002699:Chlorambucil / Q000008:administration & dosage / Q000633:toxicity; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000633:toxicity*; D003545:Cysteine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005260:Female; D005313:Fetal Death / Q000139:chemically induced; D005865:Gestational Age; D005978:Glutathione / Q000494:pharmacology; D007700:Kinetics; D011247:Pregnancy; D051381:Rats; D013723:Teratogens / Q000037:antagonists & inhibitors
D013723:Teratogens; D002699:Chlorambucil; D003520:Cyclophosphamide; D005978:Glutathione; D003545:Cysteine